Cargando…

Covid-19-induced coagulopathy and observed benefits with anticoagulation

Detalles Bibliográficos
Autores principales:	Karimzadeh, Sedighe, Dong, Vinh, Hassan, Osama Gamal, Raut, Akshay, Fouda, Ahmed, Parrill, Allison, Eaton, Kimberly, Huy, Nguyen Tien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397930/ https://www.ncbi.nlm.nih.gov/pubmed/32778522 http://dx.doi.org/10.1016/j.transci.2020.102906

Ejemplares similares

COVID-19 and Pulmonary Embolism: Diagnostic Imaging Trends
por: Karimzadeh, Sedighe, et al.
Publicado: (2020)

SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients
por: Parrill, Allison, et al.
Publicado: (2021)

Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses
por: Karimzadeh, Sedighe, et al.
Publicado: (2021)

Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients
por: Ahmed, Syed Imran, et al.
Publicado: (2020)

COVID-19 presenting as acute pancreatitis: Lessons from a patient in Iran
por: Karimzadeh, Sedighe, et al.
Publicado: (2020)

Impediments to child education, health and development during the COVID-19 pandemic in India
por: Raut, Akshay, et al.
Publicado: (2022)

Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?
por: Raut, Akshay, et al.
Publicado: (2021)

Reply to “Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy”
por: Coto‐Hernández, Rubén, et al.
Publicado: (2020)

Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'
por: Tang, Ning
Publicado: (2020)

Coagulopathy in COVID-19 and anticoagulation clinical trials
por: Zhang, Heng, et al.
Publicado: (2022)

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
por: Miesbach, Wolfgang, et al.
Publicado: (2020)

COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation
por: Salabei, Joshua K, et al.
Publicado: (2021)

Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry
por: Katz, Daniel, et al.
Publicado: (2021)

From lockdown to vaccines: challenges and response in Nepal during the COVID-19 pandemic
por: Kansakar, Sajog, et al.
Publicado: (2021)

COVID-19: the current situation in Afghanistan
por: Shah, Jaffer, et al.
Publicado: (2020)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: Observational case series and management recommendations
por: Bahouth, Mona N., et al.
Publicado: (2019)

Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy
por: Turshudzhyan, Alla
Publicado: (2020)

Curcumin and Coagulopathy in the COVID19 Era
por: Suresh, Padmanaban S.
Publicado: (2020)

Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis
por: Aribawa, I. Gusti Ngurah Mahaalit, et al.
Publicado: (2021)

Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation
por: Mehta, Om Prakash, et al.
Publicado: (2021)

Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
por: Kollias, Anastasios, et al.
Publicado: (2021)

A problem of self-isolation in Japan: The relationship between self-isolation and COVID-19 community case
por: Ha, Nam Xuan, et al.
Publicado: (2022)

COVID-19-Associated Coagulopathy: A Case Report of Thrombosis despite Therapeutic Anticoagulation
por: Hussain, Habiba, et al.
Publicado: (2020)

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
por: Tang, Ning, et al.
Publicado: (2020)

Dermatologists’ Role in the Diagnosis and Management of Coronavirus Disease 2019 Coagulopathy
por: Shah, Payal, et al.
Publicado: (2020)

COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy
por: Chatterjee, Sabyasachi, et al.
Publicado: (2020)

Role of Dual-Energy Computed Tomography in the Identification of Monosodium Urate Deposition in Gout Patients: A Comprehensive Analysis of 828 Joints According to Structural Joint Damage
por: Nhi, Le Huu Hanh, et al.
Publicado: (2021)

Updated upper limit of normal for serum alanine aminotransferase value in Vietnamese population
por: Huong, Nguyen Thi Cam, et al.
Publicado: (2022)

COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept
por: Gris, Jean-Christophe, et al.
Publicado: (2020)

Coagulopathy profiles and their correlation with molecular viral burden in patients with COVID-19
por: Park, Hee Sue, et al.
Publicado: (2021)

RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19
por: Akima, Satoshi, et al.
Publicado: (2020)

Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry
por: Staerkle, Ralph F., et al.
Publicado: (2018)

COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19
por: Chambers, Isaac, et al.
Publicado: (2020)

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A comment
por: Barrett, Christopher D., et al.
Publicado: (2020)

Acute traumatic coagulopathy and trauma-induced coagulopathy: an overview
por: Kushimoto, Shigeki, et al.
Publicado: (2017)

Retrospective observational study of interventional radiology and critical care coagulopathy
por: Hibbs, SP, et al.
Publicado: (2014)

Circulating histones play a central role in COVID-19-associated coagulopathy and mortality
por: Shaw, Rebecca J., et al.
Publicado: (2021)

Anticoagulant therapy for septic coagulopathy and disseminated intravascular coagulation: where do KyberSept and SCARLET leave us?
por: Wiedermann, Christian J.
Publicado: (2020)

Favorable Outcomes of Anticoagulation With Unfractioned Heparin in Sepsis-Induced Coagulopathy: A Retrospective Analysis of MIMIC-III Database
por: Peng, Jiang-Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7t3b3b9bp961k86spa9g3f5k14